DexCom (NASDAQ:DXCM) is gearing up to announce its quarterly earnings on Thursday, 2026-02-12. Here’s a quick overview of what investors should know before the release.
Analysts are estimating that DexCom will report an earnings per share (EPS) of $0.65.
DexCom bulls will hope to hear the company announce they’ve not only beaten that estimate, but also to provide positive guidance, or forecasted growth, for the next quarter.
New investors should note that it is sometimes not an earnings beat or miss that most affects the price of a stock, but the guidance (or forecast).
Overview of Past Earnings
During the last quarter, the company reported an EPS beat by $0.04, leading to a 14.63% drop in the share price on the subsequent day.
Here’s a look at DexCom’s past performance and the resulting price change:
| Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 |
|---|---|---|---|---|
| EPS Estimate | 0.57 | 0.45 | 0.33 | 0.50 |
| EPS Actual | 0.61 | 0.48 | 0.32 | 0.45 |
| Price Change % | -15.00 | -9.00 | 16.00 | 6.00 |
Performance of DexCom Shares
Shares of DexCom were trading at $68.16 as of February 10. Over the last 52-week period, shares are down 19.85%. Given that these returns are generally negative, long-term shareholders are likely bearish going into this earnings release.
Analyst Observations about DexCom
For investors, grasping market sentiments and expectations in the industry is vital. This analysis explores the latest insights regarding DexCom.
The consensus rating for DexCom is Outperform, derived from …